{"id":1717,"date":"2017-01-25T17:04:01","date_gmt":"2017-01-25T22:04:01","guid":{"rendered":"http:\/\/www.ipoboutique.com\/blog\/?p=1717"},"modified":"2017-01-25T19:11:45","modified_gmt":"2017-01-26T00:11:45","slug":"secondaries-announced-01-25-2017","status":"publish","type":"post","link":"https:\/\/www.ipoboutique.com\/blog\/secondaries-announced-01-25-2017\/","title":{"rendered":"Secondaries announced 01.25.2017"},"content":{"rendered":"<p>IPOBoutique.Com rates secondary offerings to hit the tape with a \u2018BUY\u2019, \u2018NEUTRAL\u2019 or \u2018AVOID\u2019 rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary\u2019s he\u2019s issued with a \u2018BUY\u2019 rating.<\/p>\n<p>Company: Entellus Medical, Inc.<br \/>\nSymbol: ENTL<br \/>\nPrice: Last trade $19.39<br \/>\nDescription: Re-offer range $17.00-$18.00<br \/>\nTrade Date: 1\/26<br \/>\nShares: 3.1 million<br \/>\nUnderwriter(s)BofA Merrill Lynch, Piper Jaffray<br \/>\nCo Manager(s)William Blair &amp; Co.<br \/>\n<a href=\" https:\/\/www.ipoboutique.com\/Subscribe.html\">Rating=Subscription Needed<\/a><\/p>\n<p>Company: Sinovac Biotech<br \/>\nSymbol: SVA<br \/>\nPrice: Last trade $5.84<br \/>\nDescription: Re-offer $5.55<br \/>\nTrade Date: 1\/26<br \/>\nShares: 1.25 million<br \/>\nUnderwriter(s)Morgan Stanley<br \/>\n<a href=\" https:\/\/www.ipoboutique.com\/Subscribe.html\">Rating=Subscription Needed<\/a><\/p>\n<p>Company: Virtus Investment Partners, Inc.<br \/>\nSymbol: VRTS<br \/>\nPrice: Last trade $125.65<br \/>\nDescription: Convertible Preferred Stock=$100mm<br \/>\nTrade Date: 1\/27<br \/>\nShares: 800,000<br \/>\nUnderwriter(s)Barclays, Morgan Stanley, J.P. Morgan, BofA Merrill Lynch<br \/>\n<a href=\" https:\/\/www.ipoboutique.com\/Subscribe.html\">Rating=Subscription Needed<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>IPOBoutique.Com rates secondary offerings to hit the tape with a \u2018BUY\u2019, \u2018NEUTRAL\u2019 or \u2018AVOID\u2019 rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary\u2019s he\u2019s issued with a \u2018BUY\u2019 rating. Company: Entellus Medical, Inc. Symbol: ENTL Price: Last trade $19.39 Description: Re-offer range $17.00-$18.00 Trade Date: 1\/26 Shares: 3.1 million Underwriter(s)BofA Merrill[&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[35,1],"tags":[26,1044,1045],"class_list":["post-1717","post","type-post","status-publish","format-standard","hentry","category-secondary-offerings","category-uncategorized","tag-entl","tag-sva","tag-vrts"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/1717","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=1717"}],"version-history":[{"count":2,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/1717\/revisions"}],"predecessor-version":[{"id":1724,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/1717\/revisions\/1724"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=1717"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=1717"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=1717"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}